Ondine Biomedical Inc Sustainability Reports

Ondine Biomedical Inc. is a life sciences company focused on the development of light-activated antimicrobial therapies, known as photodisinfection, for the prevention and treatment of healthcare-associated infections.

Sector: Manufacturing

Country: Canada

Exchange: London Stock Exchange (AIM)

LEI: 9845005B69E07CGF4A56

FIGI: BBG013VGWYS2

3 reports from 2021 to 2025

• Ondine Biomedical Inc 2025 Annual Report and Accounts
• Ondine Biomedical Inc 2022 Annual Report and Accounts
• Ondine Biomedical Inc 2021 Annual Report